Eutylone

Eutylone, also known as bk-EBDB, is a synthetic cathinone with stimulant and entactogenic properties. It is structurally related to methylone and butylone, but has ethyl groups on both the alpha carbon and the amino nitrogen. First identified in Europe in 2013, it became increasingly common in drug seizures and forensic investigations from 2019 onward. Studies show that it affects dopamine, norepinephrine and serotonin transporters, while clinical reports include severe intoxications and deaths.

Chemistry and history

Eutylone is a methylenedioxy-substituted cathinone. Its structure contains a benzodioxole ring, a beta-keto group, an N-ethyl group and an ethyl substituent on the alpha carbon. It is a higher homologue of methylone and is structurally related to butylone, dibutylone and pentylone.

The compound was described in a British patent in 1969, but it was not developed as a medicine. Its first reported seizure in Europe occurred in Poland in June 2013. Eutylone became more prominent after N-ethylpentylone was brought under control in the United States, and it was one of the most frequently encountered synthetic stimulants in forensic submissions during 2019–2020 (Krotulski and colleagues, 2021).

Pharmacology

Eutylone has a mixed action at monoamine transporters. Laboratory experiments found that it inhibits dopamine and norepinephrine uptake, while also acting as a substrate at the serotonin transporter and producing partial serotonin release. In rat brain preparations, its effects at dopamine and norepinephrine transporters were more potent than its effects at the serotonin transporter. In mice, it produced dose-related locomotor stimulation (Eutylone and its structural isomers, 2021).

This profile differs from that of some other cathinones, which act more strongly as monoamine-releasing agents. Eutylone’s combination of uptake inhibition and serotonin-transporter substrate activity has been described as a hybrid mechanism.

Subjective effects

The PsychonautWiki profile of eutylone includes anecdotal accounts of stimulation with some entactogenic qualities: euphoria, increased energy and sociability, but also agitation and a tendency towards repeated use. These accounts cannot establish a consistent clinical profile.

Physical effects

Reported effects include stimulation, increased heart rate, sweating and reduced appetite. Some accounts mention jaw tension, tremors, nausea and difficulty sleeping. More serious reactions reported in clinical cases include hypertension, hyperthermia, seizures and cardiovascular complications.

Cognitive and emotional effects

Euphoria, increased alertness and a heightened interest in social interaction are described in user accounts. Some users report empathy and greater appreciation of music, while others describe anxiety, agitation, confusion or paranoia. The balance between these effects varies, and the reports do not show how often each occurs.

Clinical and forensic findings

Between January 2019 and April 2020, eutylone was confirmed in 83 forensic investigations in the United States, including post-mortem and drug-impaired driving cases. The study included 22 post-mortem cases and identified three metabolites in authentic human samples (Krotulski and colleagues, 2021).

A separate report described a fatal case in which eutylone was the only recreational drug identified in toxicological analysis. A 32-year-old man experienced abnormal behaviour followed by cardiac arrest; the measured concentration in cardiac blood was 4,290 ng/g (Nakamura and colleagues, 2022).

Metabolism and toxicity

Metabolism studies have identified pathways including N-dealkylation, beta-ketone reduction, demethylenation, hydroxylation and conjugation. A 2025 study using rat liver microsomes identified eight metabolites, while a 2026 cross-species study identified twenty and found important differences between rat and human metabolism. The latter also reported time-dependent inhibition of CYP2D6 and CYP2B6 in vitro, raising a possible interaction concern for drugs processed by these enzymes (Lee and colleagues, 2026).

Clinical reports include hyperthermia, hypertension, seizures, agitation and fatal cardiovascular events. Many intoxications involve other substances, but the single-substance fatal case shows that severe toxicity cannot always be attributed to polydrug exposure. The available evidence does not establish a reliable concentration threshold for toxicity.

Related compounds

Eutylone is related to Butylone, Ethylone, Ephylone and Methylone. These compounds share a methylenedioxy-cathinone framework but differ in their alpha-carbon and nitrogen substituents.